...
首页> 外文期刊>Seminars in cell and developmental biology >Alternative splicing in cancers: From aberrant regulation to new therapeutics
【24h】

Alternative splicing in cancers: From aberrant regulation to new therapeutics

机译:癌症中的替代剪接:从异常调节到新的治疗方法

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Alternative splicing is one of the most common mechanisms for gene regulation in humans, and plays a vital role to increase the complexity of functional proteins. In this article, we seek to provide a general review on the relationships between alternative splicing and tumorigenesis. We briefly introduce the basic rules for regulation of alternative splicing, and discuss recent advances on dynamic regulation of alternative splicing in cancers by highlighting the roles of a variety of RNA splicing factors in tumorigenesis. We further discuss several important questions regarding the splicing of long noncoding RNAs and back-splicing of circular RNAs in cancers. Finally, we discuss the current technologies that can be used to manipulate alternative splicing and serve as potential cancer treatment. (c) 2017 Elsevier Ltd. All rights reserved.
机译:替代剪接是人类基因调控的最常见机制之一,并发挥至关重要的作用,以提高功能蛋白的复杂性。 在本文中,我们寻求关于替代剪接和肿瘤内酯之间的关系提供一般性综述。 我们简要介绍了替代剪接调节的基本规则,并讨论了最近通过突出各种RNA剪接因子在肿瘤发生中的作用来探讨癌症中替代剪接的动态调节。 我们进一步讨论了关于癌症循环循环RNA的剪接和循环循环的几个重要问题。 最后,我们讨论了可用于操纵替代剪接并用作潜在癌症治疗的当前技术。 (c)2017 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号